AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
PARIS -- Most karyotypically normal fetuses with elevated nuchal translucency at 11-14 weeks will be born without major abnormalities, Dr. Katia Bilardo reported at the 13th World Congress on Ultrasound in Obstetrics and Gynecology.
Sonographic assessment of nuchal translucency (NT) at 11-14 weeks' gestation is a recognized effective screening method for trisomy 21 and other chromosomal abnormalities. Up to 80% of aneuploid fetuses have increased NT, but so do 3%-5% of karyotypically normal fetuses, said Dr. Bilardo of the Academic Medical Centre, Amsterdam.
Over a 9-year period, 67% of 560 fetuses with elevated NT at 11-14 weeks had normal karyotypes. Of those 376, 81% were normal (detected by subsequent scans or after birth) while 19% had major adverse outcomes, including structural ...